The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused ...
May 31, 2023
0
22
An article published in the Canadian Medical Association Journal describes five things clinicians and harm reduction workers should know about xylazine, a veterinary medication adulterating the illicit opioid supply.
Feb 5, 2024
0
0
A gene-silencing therapy protected against Zika virus transmission from pregnant mice to the mouse fetuses, finds a study published November 10th in the journal Molecular Therapy. The treatment, which harnesses nanoparticles ...
Nov 10, 2021
0
22
(Medical Xpress)—Lung cancer kills about 1.5 million men and women around the world – more than the number of people who die from breast, colon, pancreatic and prostate cancers combined.
Jun 10, 2013
0
0
The U.S. Food and Drug Administration approved the combination of tremelimumab (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer with no sensitizing ...
Nov 16, 2022
0
47
With the number of liver transplants performed at the University of Chicago Medicine on track to reach a 20-year high, a new study by the institution's researchers reinforces the growing popularity and safety of using livers ...
Jul 23, 2020
0
1
Forty years after the discovery of HIV, AFP looks at how far we have come in fighting a deadly virus that was once shrouded in fear and shame but is now treated as a manageable chronic condition.
May 10, 2023
0
4
Eight of the top 10 selling drugs in the United States are biologics, which are produced from living organisms or certain components of living organisms. Subcutaneous injection—where the drug is injected into the tissue ...
Jan 15, 2020
0
0
Indiana's governor authorized a short-term needle-exchange program and other steps Thursday to help contain the spread of HIV in a county tied to 79 new infections since January, all of them linked to intravenous drug use.
Mar 26, 2015
0
4
(HealthDay)—Zerbaxa (ceftolozane and tazobactam) has been approved for a new indication to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years ...
Jun 4, 2019
0
2
